{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:15:12Z","timestamp":1790342112589,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12478-x","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T12:07:55Z","timestamp":1770120475000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The impact of COVID-19 non-pharmaceutical interventions on notifiable infectious diseases in Poland: a comprehensive analysis from 2014\u20132022"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9619-381X","authenticated-orcid":false,"given":"Abdulla Zahi","family":"Hourani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7493-4537","authenticated-orcid":false,"given":"Abdelrahman","family":"Abdelsalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4934-4391","authenticated-orcid":false,"given":"Arman David","family":"S\u00fcrmeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"12478_CR1","unstructured":"COVID-Coronavirus Statistics - Worldometer [Internet]. Available from: https:\/\/www.worldometers.info\/coronavirus\/. [cited 2024 Oct 29]."},{"key":"12478_CR2","unstructured":"COVID-19 cases | WHO COVID-19 dashboard [Internet]. World health organization Data. Available from: https:\/\/data.who.int\/dashboards\/covid19\/cases. [cited 2024 Oct 29]."},{"issue":"10227","key":"12478_CR3","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1016\/S0140-6736(20)30493-1","volume":"395","author":"S Spina","year":"2020","unstructured":"Spina S, Marrazzo F, Migliari M, Stucchi R, Sforza A, Fumagalli R. The response of Milan\u2019s emergency Medical System to the COVID-19 outbreak in Italy. Lancet. 2020, Mar, 14;395(10227):e49\u201350.","journal-title":"Lancet"},{"issue":"1","key":"12478_CR4","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1186\/s12889-021-11529-7","volume":"21","author":"E Bonnet","year":"2021","unstructured":"Bonnet E, Bodson O, Le Marcis F, Faye A, Sambieni NE, Fournet F, et al. The COVID-19 pandemic in francophone West Africa: from the first cases to responses in seven countries. BMC Public Health. 2021, Aug, 2;21(1):1490.","journal-title":"BMC Public Health"},{"issue":"7820","key":"12478_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41586-020-2405-7","volume":"584","author":"S Flaxman","year":"2020","unstructured":"Flaxman S, Mishra S, Gandy A, Unwin HJT, Mellan TA, Coupland H, et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020, Aug;584(7820):257\u201361.","journal-title":"Nature"},{"issue":"7","key":"12478_CR6","doi-asserted-by":"publisher","first-page":"e0253116","DOI":"10.1371\/journal.pone.0253116","volume":"16","author":"T Hale","year":"2021","unstructured":"Hale T, Angrist N, Hale AJ, Kira B, Majumdar S, Petherick A, et al. Government responses and COVID-19 deaths: global evidence across multiple pandemic waves. PLoS One. 2021;16(7):e0253116.","journal-title":"PLoS One"},{"issue":"19","key":"12478_CR7","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1001\/jama.2020.6173","volume":"323","author":"H Sakamoto","year":"2020","unstructured":"Sakamoto H, Ishikane M, Ueda P. Seasonal influenza activity during the SARS-CoV-2 outbreak in Japan. JAMA. 2020, May, 19;323(19):1969\u201371.","journal-title":"Jama"},{"key":"12478_CR8","doi-asserted-by":"publisher","first-page":"100103","DOI":"10.1016\/j.lanepe.2021.100103","volume":"6","author":"A Ullrich","year":"2021","unstructured":"Ullrich A, Schranz M, Rexroth U, Hamouda O, Schaade L, Diercke M, et al. Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: an analysis of national surveillance data during week 1\u20132016 - week 32-2020. Lancet Reg Health Eur. 2021, Jul;6:100103.","journal-title":"Lancet Reg Health Eur"},{"key":"12478_CR9","doi-asserted-by":"crossref","unstructured":"Adegbija O, Walker J, Smoll N, Khan A, Graham J, Khandaker G. Notifiable diseases after implementation of COVID-19 public health prevention measures in Central Queensland, Australia. Commun Dis Intell. 2018. 2021, Feb, 26;45.","DOI":"10.33321\/cdi.2021.45.11"},{"issue":"37","key":"12478_CR10","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.15585\/mmwr.mm6937a6","volume":"69","author":"SJ Olsen","year":"2020","unstructured":"Olsen SJ, Azziz-Baumgartner E, Budd AP, Brammer L, Sullivan S, Pineda RF, et al. Decreased influenza activity during the COVID-19 pandemic - United States, Australia, Chile, and South Africa, MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1305\u201309.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"12478_CR11","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.3201\/eid2610.203193","volume":"26","author":"HH Lee","year":"2020","unstructured":"Lee HH, Lin SH. Effects of COVID-19 prevention measures on other common infections, Taiwan. Emerg Infect Dis. 2020, Oct;26(10):2509\u201311.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"12478_CR12","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1186\/s12879-022-07496-y","volume":"22","author":"J Yan","year":"2022","unstructured":"Yan J, Li Y, Zhou P. Impact of COVID-19 pandemic on the epidemiology of STDs in China: based on the GM (1, 1) model. BMC Infect Dis. 2022, Jun, 4;22(1):519.","journal-title":"BMC Infect Dis"},{"key":"12478_CR13","doi-asserted-by":"publisher","first-page":"737817","DOI":"10.3389\/fpubh.2021.737817","volume":"9","author":"X Yan","year":"2021","unstructured":"Yan X, Wang X, Zhang X, Wang L, Zhang B, Jia Z. The epidemic of Sexually transmitted diseases under the influence of COVID-19 in China. Front Public Health. 2021;9:737817.","journal-title":"Front Public Health"},{"key":"12478_CR14","doi-asserted-by":"publisher","first-page":"e924702","DOI":"10.12659\/MSM.924702","volume":"26","author":"M Gujski","year":"2020","unstructured":"Gujski M, Raciborski F, Jankowski M, Nowicka PM, Rakocy K, Pinkas J. Epidemiological analysis of the First 1389 cases of COVID-19 in Poland: a preliminary report. Med Sci Monit. 2020, May, 7;26:e924702.","journal-title":"Med Sci Monit"},{"key":"12478_CR15","unstructured":"Bulletins, reports, epidemiological information [Internet]. Department of epidemiology and surveillance of infectious diseases. Available from: https:\/\/wwwold.pzh.gov.pl\/oldpage\/epimeld\/index_p.html. [cited 2024 Oct 29]."},{"key":"12478_CR16","unstructured":"OxCGRT\/covid-policy-tracker [Internet]. Oxford Covid-19 Government Response Tracker. 2024. Available from: https:\/\/github.com\/OxCGRT\/covid-policy-tracker. [cited 2024 Oct 29]."},{"issue":"18","key":"12478_CR17","doi-asserted-by":"publisher","first-page":"2200452","DOI":"10.2807\/1560-7917.ES.2023.28.18.2200452","volume":"28","author":"I Paradowska-Stankiewicz","year":"2023","unstructured":"Paradowska-Stankiewicz I, Pancer K, Pozna\u0144ska A, Hordowicz M, Skibicka M, S\u0142owi\u0144ski M, et al. Tick-borne encephalitis epidemiology and surveillance in Poland, and comparison with selected European countries before and during the COVID-19 pandemic & comma; 2008 to 2020. Euro Surveill. 2023, May;28(18):2200452.","journal-title":"Euro Surveill"},{"key":"12478_CR18","unstructured":"Ustawa z dnia 5 grudnia 2008 r. o zapobieganiu oraz zwalczaniu zaka\u017ce\u0144 i chor\u00f3b zaka\u017anych u ludzi. On preventing and controlling infections and infectious diseases in humans. Dz. U. 2008 Nr 234 poz. 1570. Act of 5 December 2008. Internetowy System Akt\u00f3w Prawnych; 5 Dec 2008. Polish. Available from: https:\/\/isap.sejm.gov.pl\/isap.nsf\/download.xsp\/WDU20082341570\/U\/D20081570Lj.pdf."},{"key":"12478_CR19","unstructured":"Department of Epidemiology and Surveillance of Infectious Diseases. Definicje przypadk\u00f3w chor\u00f3b zaka\u017anych na potrzeby nadzoru epidemiologicznego (67 definicji), Wersja robocza (6b). [Infectious disease case definitions for epidemiological surveillance. 2020. Polish. (67 definitions), Draft (6b)]. Warsaw: National Institute of Public Health - National Institute of Hygiene. Available from: http:\/\/wwwold.pzh.gov.pl\/oldpage\/epimeld\/inne\/Def_PL2_6b.pdf."},{"issue":"4","key":"12478_CR20","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41562-021-01079-8","volume":"5","author":"T Hale","year":"2021","unstructured":"Hale T, Angrist N, Goldszmidt R, Kira B, Petherick A, Phillips T, et al. A global panel database of pandemic policies (Oxford COVID-19 Government Response tracker). Nat Hum Behav. 2021, Apr;5(4):529\u201338.","journal-title":"Nat Hum Behav"},{"issue":"1","key":"12478_CR21","doi-asserted-by":"publisher","first-page":"6923","DOI":"10.1038\/s41467-021-27292-7","volume":"12","author":"MJ Geng","year":"2021","unstructured":"Geng MJ, Zhang HY, Yu LJ, Lv CL, Wang T, Che TL, et al. Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic. Nat Commun. 2021, Nov, 26;12(1):6923.","journal-title":"Nat Commun"},{"key":"12478_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v087.i11","volume":"87","author":"C Sax","year":"2018","unstructured":"Sax C, Eddelbuettel D. Seasonal adjustment by X-13ARIMA-SEATS in R. J Stat Softw. 2018, Dec, 20;87:1\u201317.","journal-title":"J Stat Softw"},{"issue":"449","key":"12478_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/01621459.2000.10473895","volume":"95","author":"BA Brumback","year":"2000","unstructured":"Brumback BA, Ryan LM, Schwartz JD, Neas LM, Stark PC, Burge HA. Transitional regression models, with application to environmental time series. J Am Stat Assoc. 2000;95(449):16\u201327.","journal-title":"J Am Stat Assoc"},{"key":"12478_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.envres.2015.06.040","volume":"142","author":"C Imai","year":"2015","unstructured":"Imai C, Armstrong B, Chalabi Z, Mangtani P, Hashizume M. Time series regression model for infectious disease and weather. Environ Res. 2015, Oct;142:319\u201327.","journal-title":"Environ Res"},{"key":"12478_CR25","doi-asserted-by":"crossref","unstructured":"Chen B, Wang M, Huang X, Xie M, Pan L, Liu H, et al. Changes in incidence of notifiable infectious diseases in China under the prevention and Control measures of COVID-19. Front Public Health [Internet]. 2021 Oct 15. 9. Available from: https:\/\/www.frontiersin.org\/journals\/public-health\/articles\/10.3389\/fpubh.2021.728768\/full. [cited 2024 Oct 29].","DOI":"10.3389\/fpubh.2021.728768"},{"issue":"12","key":"12478_CR26","doi-asserted-by":"publisher","first-page":"1437485","DOI":"10.3389\/fpubh.2024.1437485","volume":"31","author":"J Hausmann","year":"2024","unstructured":"Hausmann J, D\u00f6rre A, Katz K, van de Berg S. Lifting COVID-19-associated non-pharmaceutical interventions: potential impact on notifications of infectious diseases transmitted from person to person in 2022 in Bavaria, Germany. Front Public Health. 2024, Jul;31(12):1437485. https:\/\/doi.org\/10.3389\/fpubh.2024.1437485.","journal-title":"Front Public Health"},{"key":"12478_CR27","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1186\/s12889-024-19799-7","volume":"24","author":"D Costa","year":"2024","unstructured":"Costa D, Rohleder S, Bozorgmehr K. Impact of non-pharmaceutical interventions on COVID-19 incidence and deaths: cross-national natural experiment in 32 European countries. BMC Public Health. 2024;24:2341. https:\/\/doi.org\/10.1186\/s12889-024-19799-7.","journal-title":"BMC Public Health"},{"key":"12478_CR28","doi-asserted-by":"publisher","first-page":"108484","DOI":"10.1016\/j.mbs.2020.108484","volume":"330","author":"J Ge","year":"2020","unstructured":"Ge J, He D, Lin Z, Zhu H, Zhuang Z. Four-tier response system and spatial propagation of COVID-19 in China by a network model. Math Biosci. 2020, Oct, 9;330:108484.","journal-title":"Math Biosci"},{"issue":"2","key":"12478_CR29","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s40471-015-0041-9","volume":"2","author":"JD Cherry","year":"1906","unstructured":"Cherry JD. The history of pertussis (whooping cough). Curr Epidemiol Rep. 1906-2015. Facts Myths Misconceptions. 2015 Jun;12(2):120\u201330.","journal-title":"Curr Epidemiol Rep"},{"key":"12478_CR30","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.2147\/IJGM.S343940","volume":"15","author":"Y Lu","year":"2022","unstructured":"Lu Y, Wang Y, Shen C, Luo J, Yu W. Decreased incidence of influenza during the COVID-19 pandemic. Int J Gen Med. 2022;15:2957\u201362.","journal-title":"Int J Gen Med"},{"key":"12478_CR31","doi-asserted-by":"publisher","first-page":"e2022011","DOI":"10.4178\/epih.e2022011","volume":"44","author":"S Kim","year":"2022","unstructured":"Kim S, Kim J, Choi BY, Park B. Trends in gastrointestinal infections before and during non-pharmaceutical interventions in Korea in comparison with the United States. Epidemiol Health. 2022, Jan, 3;44:e2022011.","journal-title":"Epidemiol And Health"},{"key":"12478_CR32","unstructured":"CDC. Norovirus. How norovirus spreads. Available from: 2024. https:\/\/www.cdc.gov\/norovirus\/causes\/index.html. [cited 2024 Oct 29]."},{"key":"12478_CR33","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.ijmm.2024.151600","volume":"314","author":"S Jacobsen","year":"2024","unstructured":"Jacobsen S, Faber M, Altmann B, Mas Marques A, Bock CT, Niendorf S. Impact of the COVID-19 pandemic on norovirus circulation in Germany. Int J Med Microbiol. 2024, Mar;314:1516.","journal-title":"Int J Med Microbiol"},{"issue":"4","key":"12478_CR34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1136\/sextrans-2020-054802","volume":"97","author":"CC Chia","year":"2021","unstructured":"Chia CC, Chao CM, Lai CC. Diagnoses of syphilis and HIV infection during the COVID-19 pandemic in Taiwan. Sex Transm Infect. 2021, Jun, 1;97(4):319\u2013319.","journal-title":"Sex Transm Infect"},{"issue":"5","key":"12478_CR35","doi-asserted-by":"publisher","first-page":"630","DOI":"10.7150\/ijms.30739","volume":"16","author":"C Teng","year":"2019","unstructured":"Teng C, Reveles KR, Obodozie-Ofoegbu OO, Frei CR. Clostridioides difficile infection risk with important antibiotic classes: an analysis of the FDA adverse event reporting System. Int J Med Sci. 2019, May, 7;16(5):630.","journal-title":"Int J Med Sci"},{"issue":"5","key":"12478_CR36","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.ajic.2020.09.010","volume":"49","author":"E Bentivegna","year":"2021","unstructured":"Bentivegna E, Alessio G, Spuntarelli V, Luciani M, Santino I, Simmaco M, et al. Impact of COVID-19 prevention measures on risk of health care-associated Clostridioides difficile infection. Am J Infect Control. 2021, May;49(5):640\u201342.","journal-title":"Am J Infect Control"},{"issue":"11","key":"12478_CR37","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.ajic.2020.06.209","volume":"48","author":"KM McMullen","year":"2020","unstructured":"McMullen KM, Smith BA, Rebmann T. Impact of SARS-CoV-2 on hospital acquired infection rates in the United States: predictions and early results. Am J Infect Control. 2020, Nov, 1;48(11):1409\u201311.","journal-title":"Am J Infect Control"},{"issue":"4","key":"12478_CR38","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ajic.2020.10.019","volume":"49","author":"LEI Wee","year":"2021","unstructured":"Wee LEI, Conceicao EP, Tan JY, Magesparan KD, Amin IBM, Ismail BBS, et al. Unintended consequences of infection prevention and control measures during COVID-19 pandemic. Am J Infect Control. 2021, Apr;49(4):469\u201377.","journal-title":"Am J Infect Control"},{"issue":"3","key":"12478_CR39","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3390\/idr15030028","volume":"15","author":"RU Awan","year":"2023","unstructured":"Awan RU, Gangu K, Nguyen A, Chourasia P, Borja Montes OF, Butt MA, et al. COVID-19 and Clostridioides difficile coinfection outcomes among hospitalized patients in the United States: an insight from national inpatient database. Infect Dis Rep. 2023, May, 19;15(3):279\u201391.","journal-title":"Infect Dis Rep"},{"key":"12478_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jhin.2024.04.002","volume":"149","author":"C Vicentini","year":"2023","unstructured":"Vicentini C, et al. Impact of COVID-19 on healthcare-associated infections and antimicrobial use in Italy, 2022. J Hosp Infect. 2023;149:14\u201321.","journal-title":"J Hosp Infect"},{"issue":"12","key":"12478_CR41","first-page":"e20397","volume":"13","author":"S Yadlapati","year":"2021","unstructured":"Yadlapati S, Jarrett SA, Lo KB, Sweet J, Judge TA. Examining the rate of Clostridioides (formerly Clostridium) difficile infection pre- and Post-COVID-19 pandemic: an institutional Review. Cureus. 2021, Dec, 13;13(12):e20397.","journal-title":"Cureus"},{"key":"12478_CR42","doi-asserted-by":"crossref","unstructured":"Luo Y, Grinspan LT, Fu Y, Adams-Sommer V, Willey DK, Patel G, et al. Hospital-onset Clostridioides difficile infections during the COVID-19 pandemic. Infect Control and Hosp Epidemiol. 2020, Sep, 23;1.","DOI":"10.1017\/ice.2020.1223"},{"key":"12478_CR43","unstructured":"Regulation of the Council of Ministers of 10 April 2020 on establishing certain restrictions, orders and prohibitions in connection with the state of epidemic. Dz U. 2020 Poz658. Mandated face coverings in public from 16 April 2020."},{"key":"12478_CR44","doi-asserted-by":"publisher","DOI":"10.4467\/2543859XPKG.20.007.12105","author":"M Tarkowski","year":"2020","unstructured":"Tarkowski M, Puzdrakiewicz K, Jaczewska J, Po\u0142om M. COVID-19 lockdown in Poland - changes in regional and local mobility patterns based on Google maps data. Prace Komisji Geografii Komunikacji PTG. 2020. https:\/\/doi.org\/10.4467\/2543859XPKG.20.007.12105.","journal-title":"Prace Komisji Geografii Komunikacji PTG"},{"issue":"4","key":"12478_CR45","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/economies8040078","volume":"8","author":"M Wielechowski","year":"2020","unstructured":"Wielechowski M, Czech K, Grz\u0119da \u0141. Decline in mobility: public transport in Poland in the time of the COVID-19 pandemic. Economies. 2020;8(4):78. https:\/\/doi.org\/10.3390\/economies8040078.","journal-title":"Economies"},{"issue":"21","key":"12478_CR46","doi-asserted-by":"publisher","first-page":"14455","DOI":"10.3390\/ijerph192114455","volume":"19","author":"A Strzelecki","year":"2022","unstructured":"Strzelecki A, Azevedo A, Rizun M, Rutecka P, Zaga\u0142a K, Cicha K, et al. Human mobility restrictions and COVID-19 infection rates: analysis of mobility data and coronavirus spread in Poland and Portugal. Int J Environ Res Public Health. 2022;19(21):14455. https:\/\/doi.org\/10.3390\/ijerph192114455.","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"12478_CR47","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S1473-3099(20)30984-1","volume":"21","author":"NG Davies","year":"2021","unstructured":"Davies NG, Barnard RC, Jarvis CI, Russell TW, Semple MG, Jit M, et al. Association of tiered restrictions and a second lockdown with COVID-19 deaths and hospital admissions in England: a modelling study. Lancet Infect Dis. 2021, Apr, 1;21(4):482\u201392.","journal-title":"The Lancet Infect Dis"},{"issue":"1","key":"12478_CR48","doi-asserted-by":"publisher","first-page":"5106","DOI":"10.1038\/s41467-020-18827-5","volume":"11","author":"F Della Rossa","year":"2020","unstructured":"Della Rossa F, Salzano D, Di Meglio A, De Lellis F, Coraggio M, Calabrese C, et al. A network model of Italy shows that intermittent regional strategies can alleviate the COVID-19 epidemic. Nat Commun. 2020, Oct, 9;11(1):5106.","journal-title":"Nat Commun"},{"issue":"5","key":"12478_CR49","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.idnow.2021.05.004","volume":"51","author":"R Cohen","year":"2021","unstructured":"Cohen R, Ashman M, Taha MK, Varon E, Angoulvant F, Levy C, et al. Pediatric infectious disease group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap? Infect Dis Now. 2021, May, 12;51(5):418.","journal-title":"Infect Dis Now"},{"key":"12478_CR50","unstructured":"Cohen R, Levy C, Rybak A, Angoulvant F, Ouldali N, Grimprel E. Immune debt: recrudescence of disease and confirmation of a contested concept. Infectious Diseases."},{"issue":"1","key":"12478_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/vim.2022.0204","volume":"36","author":"RF Needle","year":"2023","unstructured":"Needle RF, Russell RS. Immunity debt, a gap in learning, or immune dysfunction? Viral Immunol. 2023, Jan;36(1):1\u20132.","journal-title":"Viral Immunol"},{"issue":"1","key":"12478_CR52","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12889-023-15081-4","volume":"23","author":"Z Zuo","year":"2023","unstructured":"Zuo Z, Yang C, Ye F, Wang M, Wu J, Tao C, et al. Trends in respiratory diseases before and after the COVID-19 pandemic in China from 2010 to 2021. BMC Public Health. 2023, Feb, 1;23(1):217.","journal-title":"BMC Public Health"},{"key":"12478_CR53","unstructured":"Rosi\u0144ska M, Czarkowski MP, Sadkowska-Todys M. Infectious diseases in Poland in 2020. Przegl Epidemiol. 2022. Available from: https:\/\/www.przeglepidemiol.pzh.gov.pl\/pdf-181094-101655?filename=Infectious%20diseases%20in.pdf."},{"issue":"4","key":"12478_CR54","doi-asserted-by":"publisher","first-page":"524","DOI":"10.32394\/pe\/202170","volume":"78","author":"M Rosi\u0144ska","year":"2024","unstructured":"Rosi\u0144ska M, Czarkowski MP, Sadkowska-Todys M. Infectious diseases in Poland in 2022. Przegl Epidemiol. 2024;78(4):524\u201342. https:\/\/doi.org\/10.32394\/pe\/202170. Available from: https:\/\/www.przeglepidemiol.pzh.gov.pl\/pdf-202170-123412.","journal-title":"Przegl Epidemiol"},{"key":"12478_CR55","doi-asserted-by":"crossref","unstructured":"Rosi\u0144ska M, Czarkowski MP, Sadkowska-Todys M. Infectious diseases in Poland in 2021. Przegl Epidemiol. 2023. Available from: https:\/\/www.przeglepidemiol.pzh.gov.pl\/pdf-186514-110131.","DOI":"10.32394\/pe.77.36"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12478-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12478-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12478-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T08:48:59Z","timestamp":1770281339000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12478-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12478"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12478-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"3 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study analyzed anonymized, aggregate data from Poland\u2019s national notifiable disease surveillance (NIZP PZH\u2013PIB\/State Sanitary Inspection, EpiBaza). No individual-level or identifiable information was used; no new human or animal data were collected. In accordance with applicable regulations and institutional policies, ethical approval and informed consent were not required for analyses of publicly available, aggregate surveillance data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"271"}}